Clarfeld Financial Advisors’s Boston Scientific BSX Stock Holding History

Clarfeld Financial Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$9K	Buy	+240	New	+$8.7K	0.01%	236

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Clarfeld Financial Advisors's BSX Position: Q4 2018 in Review

Clarfeld Financial Advisors opened a new position in Boston Scientific (BSX) in Q4 2018: 240 shares worth $9K. The stake represents 0.01% of the portfolio and ranks #236 among its holdings.

731 funds tracked by Wall St. Rank hold BSX as of Q4 2018.

Clarfeld Financial Advisors held 240 shares of Boston Scientific worth $9K as of Q4 2018.
Boston Scientific was a new Clarfeld Financial Advisors position in Q4 2018.
Boston Scientific made up 0.01% of Clarfeld Financial Advisors's portfolio in Q4 2018, its #236 holding.
731 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2018.

Based on Clarfeld Financial Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.